J CLIN GASTROENTEROL 润色咨询

JOURNAL OF CLINICAL GASTROENTEROLOGY

出版年份：1979 年文章数：2971 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2019-09-04 fzdndx

    投稿一个月了还是with editor？

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2021-03-12 sky110319

    投稿20天，仍with editor

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2020-02-24 土土zz

    老师咨询下，这个杂志版面费多少huihui233 2020-01-01 00:00:00 发表:
    9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投

    huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2020-11-14 ms8000000795475178

    请问接受综述吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2020-03-21 1861eaa8b6m

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2020-01-01 huihui233

    9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    就是时间长一点

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2019-08-21 cho1412

    请问这个杂志可以接受共同第一作者吗，谢谢！

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-08-19 july大大大大小姐

    综述可以接受投稿吗？还是只接受稿约？

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=575821, encodeId=63635e5821c1, content=投稿一个月了还是with editor？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947756, encodeId=cbcb94e75618, content=投稿20天，仍with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Fri Mar 12 22:39:14 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585255, encodeId=c12158525592, content=老师咨询下，这个杂志版面费多少<span class="quote">huihui233 2020-01-01 00:00:00 发表:<br>9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投</span>, beContent=huihui233 2020-01-01 00:00:00 发表: 9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/30/8f37ec5799ecca7208b819907ba7cd68.jpg, createdBy=85b12332727, createdName=土土zz, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899221, encodeId=765c8992211e, content=请问接受综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecde5425294, createdName=ms8000000795475178, createdTime=Sat Nov 14 23:22:04 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587081, encodeId=7a0758e081d0, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：3月10号投，一直with editor，20号拒稿，编辑审稿，不合适，没有送外审，没有审稿意见，推荐转投Medicine。 Your manuscript has been reviewed internally by the Editors of the Journal of Clinical Gastroenterology. I am sorry to inform you that its priority rating was not sufficiently high to warrant our accepting it for review or publication. We receive more manuscripts than we can publish and, as a result, we are forced to make priority decisions. The judgment about priority is made in view of the many other papers we receive and our space limitations. Thus, even informative papers have to be rejected on occasion. This preliminary review is done on all papers so that authors can receive a quick decision if it is going to be negative. PUBLISHER TRANSFER OPTION Important Note: This option is provided to authors at the sole discretion of Wolters Kluwer Health, and does not modify the editorial decision of this journal, nor does it imply any endorsement for publication by this journal’s editorial board. Wolters Kluwer Health now provides the option to have your manuscript transferred to Medicine, an open access journal published online by Wolters Kluwer Health. Transfer is not a guarantee of publication, and submissions to Medicine will undergo a separate review by the Medicine editorial board. Article Processing Charges (APCs) will apply to accepted articles. Although I cannot offer good news at this time, I would like to express my appreciation that you considered our Journal and for the opportunity to review your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 21 00:00:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582494, encodeId=188358249480, content=9月投稿，11月大修，修回半月接收，审稿人意见不偏激有价值，值得一投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/22/a786206210efbc3d2f7165ec7ead6547.jpg, createdBy=d9ce2329140, createdName=huihui233, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578796, encodeId=03655e8796bf, content=就是时间长一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575111, encodeId=3c3e5e511164, content=请问这个杂志可以接受共同第一作者吗，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d172417177, createdName=cho1412, createdTime=Wed Aug 21 10:05:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560215, encodeId=75e356021538, content=综述可以接受投稿吗？还是只接受稿约？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/33C0BDEFA7221AC34133E5ED52250BF3/100, createdBy=61892302524, createdName=july大大大大小姐, createdTime=Sun Aug 19 09:07:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557756, encodeId=76b455e756cf, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c52255767, createdName=12173988m66(暂无昵称), createdTime=Fri Jun 08 16:06:00 CST 2018, time=2018-06-08, status=1, ipAttribution=)]
    2018-06-08 12173988m66(暂无昵称)

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：WOS显示该杂志美国投稿占49%.其次是日本.中国投稿占1.4%.审稿快.编辑非常友好.仅供参考.

    0

共56条页码: 2/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分